Untitled Document
CRU Organization
 


Punnee Pitisuttithum

Education
Administrative Appointments
Academic Appointments
Training
Memberships
Areas of Specialization / Expertise
Research Activities
Publications
 
 
 
CRU Organization 2006 > Professor Punnee Pitisuttithum M.B.,B.S.,D.T.M,& H. Dip.
Thai Board of Int. Med. F.R.C.P.(T)
 
 

CURRICULUM VITAE

   
Name: Professor Punnee Pitisuttithum
M.B.,B.S.,D.T.M,& H. Dip. Thai Board of Int. Med. F.R.C.P.(T)
Office Address: Faculty of Tropical Medicine Mahidol University
420/6 Ratchavithi Road, Bangkok 10400, Thailand.
Tel: (662) 3549173, 6435599, 6435584 (662) 3549100 Ext. 2060
Fax: (662) 3549174, 6435598
Mobile: (661) 8294906
E-mail Address : tmppt@mahidol.ac.th
punneep@dmc.inet.co.th
 
Education:
 
1993
Diploma Thai Board of Internal Medicine, Thai Medical Council
1992
D.C.M Faculty of Medicine, Ramathibodee, Mahidol University, Bangkok.
1984
D.T.M. & H. Bangkok School of Tropical Medicine,Faculty of Tropical Medicine, Mahidol University,Bangkok.
1982

M.B.,B.S. Lady Hardinges Medical College,Delhi, University,N-Delhi

1978
Premedical Science, Mahidol University, Bangkok.
 

 

 
 
Administrative Appointments:
 
November 2002 – to date
Member, Faculty Senate, Mahidol University, Bangkok
January 2002 – to date
Chief; Clinical Trial, Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok
August 2000 – to date
Chief of Clinical Infectious Diseases Research Unit, Department of Clinical Tropical Medicine, Mahidol University, Bangkok.
October1998 – December 2005
Deputy Head, Department of Clinical Tropical Medicine Faculty of Tropical Medicine, Mahidol University, Bangkok.
Oct. 1993 – Sept. 1996
Assistant director of the Hospital for Tropical Diseases, Bangkok.
 

 

Academic Appointments:
 
August 2004 – to date
Professor, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok.
July 1995 – to date
Associate Professor, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok.
April 1990 – July 1995
Assistant professor, Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok.
1985 – March 1990
Lecture, Department of Clinical Tropical Medicine and Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok.
Feb 2004 – 2006
Advisory member in the advisory committee to Initiative for Vaccine Research, WHO
Feb 2004
Adhoc member, Progress in the development and evaluation of HIV-1 preventive vaccines and related regulatory issues.
Feb 2004
Temporary Advisor, WHO – UNAIDS Informal Consultation “Scientific Considerations for Evaluation of HIV Vaccines and Related Regulatory Perspectives”
Jan 2004
Adhoc member, The Global HIV Vaccine Enterprise's clinical Trials Capacity Working Group.
Dec 2003
Temporary Advisor, WHO Informal Consultation on Characterization and Quality Aspect Of Vaccines Based On Live Viral Vectors.
August 2000 – July 2003
Member of Global Alliance for Vaccines and Immunization, Task force on Research and Development.
May 2003
Temporary Advisor, Technical consultation on HPV vaccine efficacy outcome.
November 2001
Temporary Advisor, WHO workshop on “Key issues in the design of Human Pappillomavirus Vaccine trials in developing countries.”
October 2001
Temporary Advisor, WHO Informal Consultation on Clinical Evaluation of Vaccines: Regulatory Expectations.
June 2001
Temporary Advisor, Global Vaccine Research Forum, Eurotel Riviera, Montreux.
May 2001
Temporary Advisor, GAVI – Fast Tracking Rotavirus Vaccine Development And Introduction in Developing Countries.
April 2001
Temporary Advisor, Task Force on Research & Development Pneumococal vaccine meeting.
March 2001
Temporary Advisor, WHO – UNAIDS Informal Consultation: “Scientific Considerations for Evaluation of HIV Vaccines and Related Regulatory Perspectives.”
Sept. 2000 – Sept. 2002
Member of the Advisory committee on prevention and control of diseases Preventable by Center Diseases Control Thai Ministry of Public Health.
 

 

 
Training:
 
2005
2005 WHO-GCP Workshop, Bangkok, Thailand

2002

2002 GCP Code of Federation Regulations.
2001
2001 Certificate completion of the Human Participants Protection Education for Research team online course by NIH.
February 2001
Pharmacovigilance : Perspective & Future Directions by SMI Group, The Hatton, London, UK.
April 1999
GCP course for clinical monitor organized by UNAIDS and TDR.
September 1996
GCP training for investigator organized by Smith Kline Beecham.
1991 –1993
Residency training in internal medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University. Bangkok.
1986
Short course training on Acute Diarrhoeal Diseases at the University of Jakarta, Indonesia.
1985
Three months training in methodology of performing vaccine trial on human subjects at the Centre for Vaccine Development, University of Maryland, Baltimore, U.S.A.
1985
Three weeks training on clinical management of Cholera and other diarrhoeal diseases at the International Centre for Diarrhoeal Disease Research, Bangladesh.
1984
Resident, Department of Clinical Tropical Medicine, and Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok.
1983
Intern, Bhumipol Adulayadej Hospital, Bangkok.
 

 

 
Memberships:
 
Royal College of Physician of Thailand.
Medical Association of Thailand.
Thai Medical Council.
Parasitology and Tropical Medicine Association of Thailand.
Thai Medical Women’s Association.
Thai Medical Society for the Study of Sexually Transmitted Diseases.
International AIDS Society.
International Infectious Disease Society.
 

 

Areas of Specialization / Expertise:
 
Tropical Diseases and in conducting vaccine trials especially Phase I and II vaccine trial – such as Cholera vaccines, AIDS vaccines, etc.
Clinical studies (Phase I/II Drug Trial) of Tropical Diseases - cryptococcal meningitis in AIDS; oral candidiasis, Chinese herbal medicine for AIDS.
 

 

Research Activities:
 
1)
Phase III HIV – 1 Preventive Vaccine Trial, “A Phase III Trial of Aventis Pasteur Live Recombinant ALVAC- HIV (vCP 1521) Priming with Vaxgen gp120 B/E (AIDSVAX? B/E) Boosting in HIV- un infected Thai Adults”. (2003 – ongoing)
2)
Immunogenicity and Safety of Quadrivalent HPV (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine in 16-to 23 – Year Old Woman When Administered Alone and A study to Evaluate the Efficacy of Quadrivalent HPV (Types 6,11,16 and 18) L1 Virus – Like Particle (VLP) Vaccine in Reducing the Incidence of HPV 6/11-, 16-. and 18- Related CIN and VaIN HPV 6/11-, 16-, and 18- Related External Genital Warts and VIN in16- to 23- Year Old Women- The F.U.T.U.R.E. Study (Females United to Unilaterally Reduce Endo- Ectocervical Disease). (2002 – ongoing)
3)
A World-wide Phase I, Dose-escalating Study of the Safety, Tolerability and Immunogenicity of a 3-Dose Regimen of the MRKAd 5 HIV-1 gag Vaccine in healthy adults. (2002-Ongoing)
4)
A Phase III Trial to Determine the Efficacy of AIDSVAXTM B/E Vaccine in IVDUs in Bangkok, Thailand. (2000 – 2003)
5)
Phase I/II trial of Pasteur Merieux Connaught (PMC) live recombinant ALVAC – HIV (vCP1521) Priming with Vaxgen gp 120 B/E (AIDSVAXTM B/E) Boost in Thai HIV – Seronegative Adults. (2000-completed)
6)
Open-Label, Treatment Protocol for the Safety and Efficacy of SCH 56592 (Oral Suspension) in the Treatment of Invasive Fungal Infections. (2001-completed)
7)
Observational Probe Study of In Vitro Immune Response Parameters to Candidate HIV – 1 Vaccine Antigens Among Subjects in Thailand. (2001-2002)
8)
Safety and Therapeutic Effects of Jin Huang Chinese Medicine in Uncomplicated HIV – 1 Patients. (2001-2003)
9)
A Retrospective Study to Establish a Historical Database on the Efficacy of Standard Antifungal Therapy in Patients with Invasive Fungal Infection. (2001-completed)
10)
Cholera Challenge in volunteers using frozen V. cholera 0139 bacteria for challenge (1999)
11)
A Phase I/II Double-blind, Placebo-controlled study of the Chiron Biocine HIV Thai Egp 120/MF 59 Vaccine Administered alone or combined with The Chiron Bioine HIV SF 2 gp 120 Antigen in healthy HIV-seronegative Thai Adults (1998 – completed)
 

 

PUBLICATIONS:
 
2005

Tansuphasawadikul S, Pitisuttithum P, Knauer AD, Supanaranond W, Kaewkungwal J, Karmacharya BM, Chovavanich A. Clinical features, etiology and short term outcomes of interstitial pneumonitis in HIV/AIDS patients. Southeast Asian J Trop Med Public Health 2005 :36(6):1469-1478

Knauer A, Das AK, Tansuphasawadikul S, Supanaranond W, Pitisuttithum P, Wernsdorfer WH. Clinical features, aetiology and short-term outcome of interstitial pneumonitis in HIV/AIDS patients at Bamrasnaradura Hospital, Nonthaburi, Thailand. Wien Klin Wochenschr 2005: 117 Supplement 4:49-55

Jenkins RA, Thapinta D, Morgan PA, Wongkamhaeng S, Sornsathapornkul P, Bussaratid V, Sontirat A, Pitisuttithum P, Thongchareoen P, Khamboonruang C, Suriyanon V, Nitayaphan S, Brown AE; Thai AIDS Vaccine Evaluation Group. Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand. J Acquir Immune Defic Syndr 2005:15:40(5):592-599

Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NP. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med 2005:2(8):e204

Pitisuttithum P, Negroni R, Graybill JR, Bustamante B, Pappas P, Chapman S, Hare RS, Hardalo CJ. Activity of posaconazole in the treatment of control nervous system fungal infections. J Antimicrob Chemother 2005:56:745-755

Tin EE, Bowonwatanuwong C, Desakorn V, Wilairatana P, Krudsood S, Pitisuttithum P. The efficacy and adverse effects of GPO-VIR (Stavudine+lamivudine+nevirapine) in treatment na?ve adult HIV patients. Southeast Asian J Trop Med Public Health 2005:36 (2):362-369

Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, Pitisuttithum P, Smithyman AM, Day NP, White NJ. Stage –dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg 2005:99 (7):517-24

Coplan PM, Gupta SB, Dubey SA, Pitisuttithum P, Nikas A, Mbewe B, Vardas E, Schechter M, Kallas EG, freed DC, fu TM, Mast CT, Puthavathana P, Kublin J, Brown Collins K, Chisi J, Pendame R, Thaler SJ, Gray G, McIntyre J, Straus WL, Condra JH, Mehrotra DV, Guess HA, Emini EA, Shiver JW. Cross-reactivity of anti-HIV-1 Tcell immune responses among the major HIV-1 Clades in HIV-1-Positive individuals from 4 continents. J Infect Dis 2005;191:1427-34.

Karnasuta C, Paris RM, Cox JH, Nitayaphan S, Pitisuttithum P, Thongcharoen P, Brown AE, Gurunathan S, Tartaglia J, Heyward WL, McNeil JG, Birx DL, de Souza MS; Thai AIDS Vaccine Evaluation Group, Thailand. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. Vaccine 2005;23:2522-9.

 

2004

Pitisutithum P. HIV-1 prophylactic vaccine trials in Thailand. Curr HIV Res 2005;3:17-30.

Pitisuttithum P, Berman PW, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai LO,Hirunras K, Kitayaporn D, Kaewkangwal J, Migasena S, Sheppard HW, Li E, Chernow M, Peterson ML, Shibata R, Heyward WL, Francis DP. Phase I/II Study of a candidate vaccine designed against the B and E subtypes of HIV-1. J Acquir Immune Defic Syndr 2004;37:1160-5.

Paris R, Bejrachandra S, Karnasuta C, Chandanayingyong D, Kunachiwa W, Leetrakool N, Prakalapakorn S, Thongcharoen P, Nittayaphan S, Pitisuttithum P, Suriyanon V, Guruthan S, McNeil JG. Brown AE, Birx DL, de Souza M. HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp 120 or oligomeric gp 160 protein boosting. Tissue Antigens 2004;64:251-6.

Nitayaphan S, Pitisuttithum P, Karnasuta C, Eamsila C, de Souza M, Morgan P, Polonis V, Benenson M, VanCott T, Ratto-Kim S, Kim J, Thapinta D, Garnern R, Bussaratid V, Singharaj P, el-Habib R, Gurunathan S, Heyward W, Birx D, McNeil J, Brown AE;Thai AIDS Vaccine Evaluation Group. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults. J Infect Dis 2004;190:702-6.

Suphak Vanichseni, Jordan W. Tappero, Punnee Pitisuttithum, Dwip Kitayaporn, Timothy D. Mastro, Eiam Vimutisunthorn, Frits van Griensven, William L. Heyward, Donald P. Francis and Kachit Choopanya for the Bangkok Vaccine Evaluation Group. Recruitment, screening and characteristics of infection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand.AIDS 2004 18:311-316

Griensven FV, KeawKungwal J, Jordan W. Tappero, Sangkum U, Pitisuttithum P, Vanichseni S, Suntharasamai P, Orelind K, Carolyn Gee, Choopanya K for the Bangkok Vaccine Evaluation Group. Lack of increased HIV riskbehavior among infection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand.AIDS 2004; 18:295- 301

 

2003

Kim JH, Pitisuttithum P, Kamboonruang C, Chuenchitra T, Mascola J, Frankel SS, DeSouza MS, Polonis V, McLinden R, Sambor A, Brown AE, Phonrat B, Rungruengthanakit K,Duliege AM, Robb ML,Mcneil J,Birx DL; Thai AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses.2003 Sep;19(9):807-16

Pitisuttithum P, Nitayaphan S, Thongcharoen P, Khamboonruang C, Kim J, De Souza M, Chuenchitra T, Garner R.P, Thapinta D, Polonis V, Ratto- Kim S,Chanbancherd P, Chiu J, Birx L.D, Duliege A.M, McNeil J.G, Brown A.E, Safety and Immunogenicity of Combinations of Recombinant Subtype E and B HIV-1 Envelop gp120 Vaccines in Healthy Thai Adults.J Infect Dis 2003; 188(2) : 219-27

Maek-A-Nantawat W, Pitisuttithum P, Phonrat B, Bussaratid V, Naksrisook S, Peonim W, Thantamnu N, Muanaum R. Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS Vaccine Trials. J Med Assoc Thai.2003; 86:299-307.

Maek-A-Nantawat W, Pitisuttithum P, Bussaratid V, Chamnachanan S, Naksrisook S, Peonim W, Thantamnu N, Muanaum R, Ngamdee S. 6-month evaluation of JinHuang “Chinese Herbal Medicine” study in asymptomatic HIV infected Thais. Southeast Asian J Trop Med PublicHealth. 2003 2003 34:379-84.

 

2002

Pitisuttithum P, Cohen MB, Phonrat B, Suthisarnsunton U, Bussaratid V, Desakorn V, Phumratanaprapin W, Singhasivanon P, Looareesuwan S, Schiff GM, Ivanoff B, Lang D. A human volunteers challenge model using frozen bacteria of the new epidemic serotype, V.cholerae O139 in Thai volunteers. Vaccine 2002; 20:920-5.

Pukrittayakamee S, Pitisuttithum P, Zhang H, Jantra A, Wanwimolruk S, White NJ. Effects of cigarette smoking on quinine pharmacokinetics in malaria. Eur J Clin Pharmacol 2002; 58:315-9.

Putong NM, Pitisuttithum P, Supanaranond W, Phonrat B, Tansuphasawadikul S, Silachamroon U, Yuda HC, Bussaratid V, Aswapokee N. Mycobacterium tuberculosis infection among HIV/AIDS patients in Thailand: clinical manifestations and outcomes. Southeast Asian J Trop Med Public Health 2002 ;33:346-51.

Bussaratid V, Tansupasawaskul S, Simpson A, Pitisuttithum P, Phonrat B, Howe P, White NJ. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.J Med Assoc Thai 2002; 85:757-64.

Desakorn V, Simpson AJ, Wuthiekanun V, Sahassananda D, Rajanuwong A, Pitisuttithum P, Howe PA, Smith MD, White NJ. Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicillosis marneffei. J Clin Microbiol 2002; 40:3179-83.

Newton PN, Thai le H, Tip NQ, Short JM, Chierakul W, Rajanuwong A, Pitisuttithum P, Chasombat S , Phonrat B, Maek-A-Nantawat W,Teaunadi R, Lalloo DG, White NJ. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. Clin Infect Dis 2002; 35:769-72.

Thapinta D, Jenkins RA, morgan PA, Chiu J, Boenim W, Bussaratid V,Chaddic C, Naksrisook S, Phonrat B, Sirijongdee N, Sornsathapornkul P, Sontirat A, Srisaengchai P, Suwanarach C, Wongkamhaeng S, Brown AE, Khamboonruang C, Nitayaphan S, Pitisuttithum P, Thongchareon P. Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand.J Acquir Immune Defic Syndr 2002; 30:503-13.

Pitisuttithum P, Nitayaphan S, M de Souza, Kim J, Polonis V, Ratoo-Kim S, Heyward W, Gurunathan S, Brown A and Thai AIDS Vaccine Evaluation Group. Live Recombinant ALVAC-HIV (vCP1521) Priming with AIDSVAX B/E Boosting in Thailand: Safety & Immunogenicity (Abstract). XIV International AIDS Conference. Barcelona July 7-12 2002.

Pitisuttithum P, Suntharasamai P, Van Griensven S, Vanichsen I, Sangkum U, Hirunras K, Migasena S and Choopanya K. Incarceration among injecting drug users (IDUs) participating in the AIDSVAX B/E vaccine efficacy trial in Bangkok Thailand (Abstract). XIV International AIDS Conference. Barcelona 2002.

 

2001

Pitisuttithum P, Tansuphasawadikul S, Simpson AJ, Howe PA, White NJ. A prospective study of AIDS-associated cryptococcal meningitis in Thailand: Treated with high-dose amphotericin B. J Infect 2001; 43:226-33.

Pitisuttithum P,The Bangkok Vaccine Evaluation Group. Thailand ‘s Success in Moving to the First Phase III HIV Vaccine Efficacy Trial in a Developing Country (Abstract). AIDS VACCINE 2001, Philadelphia , USA , September 5 – 8 , 2001p.144

Pitisuttithum P, Nitayaphan S, Phonrat B, Heyward W, Gurunathan S, Kim J, Brown A and the Thai AIDS Vaccine Evaluation Group. Safety of Live Recombinant ALVAC – HIV (vCP1521) Priming with AIDSVAXTM B/E Boosting in Thai HIV – 1 negative Participants: Preliminary Results (Abstract). 6th International Congress on AIDS in Asia and the Pacific , Melbourne , Australia , October 5 – 10 , 2001

Pitisuttithum P, Choopanya K, Phonrat B, Vanichseni S, Sangkum U, Heyward W, Gee C. for the Bangkok Vaccine Evaluation Group. The Conduct of Good Clinical Practices (GCP) in the First HIV-1 Vaccine Efficacy Trial in a Developing Country – Bangkok, Thailand (Abstract). 6th International Congress on AIDS in Asia and the Pacific, Melbourne, Australia, Oct. 5-10, 2001

Meak-A-Nantawat W, Pitisuttithum P, Phonrat B, Budsaratid V, Naksrisook S, Peonim W,Thantamnu N and Muanom R, Knowledge behavioral risk and psychological assessment of Thai volunteers participating in phase I/II HIV/AIDS vaccine trials. 6th International Congress on AIDS in Asia and the Pacific Melbourne, Australia, October 5 – 10, 2001

¾ÃÃ³Õ »ÔµÔÊØ·¸Ô¸ÃÃÁ. ÇѤ«Õ¹·´Åͧà¾×èÍ»éͧ¡Ñ¹âäàÍ´Êìã¹»ÃÐà·Èä·ÂÍ´ÕµáÅлѨ¨ØºÑ¹.(Abstract) ÇѤ«Õ¹àÍ´Êì: ÃÇÁ¾ÅѧÊÒ¹ËÇѧãËéà»ç¹¨ÃÔ§. 㹡ÒÃÊÑÁÁ¹ÒÃдѺªÒµÔàÃ×èͧâäàÍ´Êì¤ÃÑé§·Õè 8, 11-13 ¡.¤. 2544 ³ ÍÔÁᾤàÁ×ͧ·Í§¸Ò¹Õ, ¹¹·ºØÃÕ

 

2000

Migasena S, Suntharasamai P, Pitisuttithum P, Kitayaporn D, Wasi C, Huang W, Vanichseni S, Koompong C, Kaewkungwal J, Raktham S, ppolito T, Hanson C, Gregory T, Heyward WL, Berman P, Francis D. AIDSVAX? (MN) in Bangkok injecting drug user: A report on safety and immunogenicity including mocrophage tropic virus neutralizing. AIDS Res Hum Retroviruses 2000; 16:655-63.

Pitisuttithum P, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai L, Kitayaporn D, Kaewkangwal J, Migasean S, Hiranrus K, Berman P, Chernow M and Francis D. Phase I/II Safety and Immunogenicity Trial of Bivalent rgp120 HIV Vaccine (AIDSVAXTM B/E) in Bangkok, Thailand-Initial Report (Abstract).The Third Annual Conference on Vaccine Research, Washington DC. April 30-May 2, 2000 p.48

Pitisuttithum P, Bangkok Vaccine Evaluation Group. Social harm monitoring among injecting drug users (IDUs) in a phase III HIV vaccine trial in Bangkok, Thailand-preliminary results.(Abstract). XII International AIDS Conference Durban, South Africa, 9-14 July 2000 p.443

Pitisuttithum P, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai L, Hiranrus K, Kitayaporn D., et al. Initial Report of a Phase I/II Safety and Immunogenicity Trial AIDSVSXTM B/E rgp120 HIV Vaccine – Bangkok, Thailand. (Abstract). XII International AIDS Conference Durban,South Africa, 9-14 July 2000

Pitisuttithum P, and Thai AIDS Vaccine Evaluation Group. Phase II Trial of HIV-1 Subtype E and B gp120 Vaccines in Seronegative Thai Adults. (Abstract). XII International AIDS Conference Durban,South Africa, 9-14 July 2000

 

1999

Pitisuttithum P, Phonrat B, Suntharasamai P, Migasena S, Bussaratid V, Francis DP, McNeil J, Brown A, Duliege AM. HIV-1 Vaccine trial at the Vaccine Trial Centre (VTC), Bangkok. (Abstract). The second annual conference on Vaccine research Bethesda, 28-30 March 1999

Pitisuttithum P, Cohen MB, Phonrat B, Suthisarnsuntorn U, Bussaratid V, Phumratanaprapin W, Singhasivanon P, Looareesuwan S, Giannella RA, Schiff GM, Ivanoff B and Lang D. Validation of a human volunteer challenge model using frozen bacteria of the new epidemic serotype V.cholerae O139. Comparison of the inoculum dose response between North American and thai volunteers (Abstract). The 35th US-Japan Cholera and other Bacterial Enteric Infectious Baltimore, MD. December 3-5 1999; p.37

Pitisuttithum P, Tongcharoen P, Khamboonruang C, Nitayaphan S, Chiu J, Brown A. and McNeil J. HIV Subtype E gp 120 Vaccine Trial (Phase II) in Seronegative Thai Adults. Kuala Lumpur, 23-27 October 1999

Pitisuttithum P, Phonrat B, Suntharasamai P, Raktham S, Srisuwanvilai L, Ktitayaporn D, Kaewkangwal J, Migasena S, Hiranrus K, Berman P and Francis D. A Phase I/II Trial to Evaluate the Safety and Immunogenicity of AIDSVAXTM B/E Vaccine Bangkok, Thailand- Priliminary Results. Kuala Lumpur, 23-27 October 1999

 

1998

Pitisuttithum P, Kambooruang C, Suntharasamai P, et al. Clinical response to HIV Thai E /MF59 vaccine administer of alone or combined with SF2 gp120 antigen in healthy volunteers (Abstract) 12th World AIDS Conference Geneva. June 28-July 3, 1998 page 636

Tansuphasawadikul S, Poprawski DM, Pitisuttithum P and Phonrat B. Non adherence in tuberculosis treatment among HIV patients attending Bamrasnaradura Hospital Nonthaburi. J Med assoc thai 1998; 81:964-9

Francis D, Gregory T, McElrath J, Belshe R, Gorse G, Migasena S, Kitayaporn D, Pitisuttithum P, et al Advancing AIDSVAXTM to Phase III Safety, Immunogenicity and Plans for Phase III . AIDS Res Human Retroviruses 1998; 14 : S 325-31

Migasina S, Simasathien S, Samakoses R, Pitisuttithum P, Heath J, Bellini W and Bennett J. Adverse impact of infections on antibody responses to measles vaccination Vaccine.1998;16(6):647-52

 

1997

Pitisuttithum P, Migasena S, Laothai A, Suntharasamai P, et al. Risk behaviour and comprehension among intravenous drug users volunteered for HIV vaccine trial. J Med Assoc Thai 1997; 80(1):47-50

Looareesuwan S, Wilairatana P, Viravan C, Vanijanonta S, Pitisuttithum P and Kyle DE. Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria. Am J Trop Med Hyg 1997; 56(6):613-7

Migasena S, Heppner DG, Kyle DE, Chongsuphajaisiddhi T, Gordon DM, Suntharasamai P, Permpanich B, Brockman A, Pitisuttithum P,et al. SPf66 malaria vaccine is safe and immunogenic in malaria native adults in Thailand. Acta Tropica 1997; 67:215-27

Pitisuttithum P, Migasena S, Suntharasamai P and Raktham S. Experience to date with vaccine trial in recovering intravenous drug users: Lesson for the future. (Abstract). 4th International Congress on AIDS in Asia and the Pacific October 25-29,1997 p.360

Suntharasamai P, Migasena S, Pitisuttithum P., et al .Recruiting recovering intravenous drug users for a HIV protective vaccine trial (Abstract). 4th international Congress on AIDS in Asia and the Pacific October 25-29,1997 p.377

Looareesuwan S, Wilairatana P, Vanijianonta S, Pitisuttithum P, Ratanapong Y and Andrial M. Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: a comparison of 5-and 7- day regimens Acta Trop 1997;30;67(3):197-205

Simasathien S, Migasena S, Bellini W, Samakoses R, Pitisuttithum P, Bupodom W, Heath J, Anderson L and Bennett J. Measles vaccination of Thai infants by intranasal and subcutaneous routes: possible interference from respiratory infections. Vaccine 1997; 15(3): 329-34

 

1996

Migasena S, Pitisuttithum P, Phonrat B. Combined Immunization of infants with oral and inactivated poliovirus vaccines:results of a randomized trial in the Gambia,Oman and Thailand. Bulletin of World Health Organization. 1996;74(3):253-68.

Pittisuttithum P, Migasena S, Suntharasamai P, Sutthan R, Perathamanond P, Wasi C,Schikan U, Peeters P and Tobia A. Hypericin: Safety and Antiretroviral activity in Thai HIV positive volunteers (Abstract). XI Interantion Conference on AIDS, Vancouver, July 7-12,1996 p.285

Migasena S, Sutharasamai P, Pitisuttithum P, Kitayaporn D, Wasi C,Vanichseni S, Koompong C, Kaewkungwal J, Raktham S, Ippolito T,Gregory T,Heyward WL and Francis DP. A phase I/II Trial of MN RGP 120 HIV-1 vaccine among injecting drug users Bangkok,Thailand Safety and Immunogenicity. (Abstract) XI Internation Conference on AIDS, Vancouver,July 7- 12,1996p.41

Looareesuwan S, Viravan C, Vanijanonta S, Wilairatana P, Pitisuttithum P and Andrial M. Comparative Clinical Trial of Artesunate followed by Mefloquine in the treatment of acute uncomplicated falciparum malaria: two-and three day regimens. Ann J Trop Med Hyg 1996; 54(2):210-3

Looareesuwan S, Wilairatana P, Vanijanonta S, Pitisuttithum P and Viravan C. Treatment of acute,uncomplicated falciparum malaria with oral dihydro artemisinin. Ann Trop Med Parasit 1996; 90(1):21-8

 

1995

Punpoowong B, Pitisuttithum P, Chindanon D, Phiboonnakit, D and Leelasuphasri S. Microsporidium: Modified technique for ligh microscopic diagnosis.J Med Assoc Thai 1995; 78(5):252-4

Pitisuttithum P, Phiboonnakit D, Chindanond D, Punpoonwong B, Leelasuphasri S and Vanijanond S. Intestinal Microsporidiosis: First reported case in Thailand. Southeast Asian J Trop Med Pub Hlth 1995; 26(2):378-80

Pitisuttithum P, Supanaranond W and Chindanond D. A randomized comparative study of albendazole and thiabendazole in chronic strongyloidasis. Southeast Asian J Trop Med Pub Helth 1995; 26(4):735-8

Migasena S, Simasathien S, Samakoses R, Pitisuttithum P, Sangaroon P, Steenis GV, Beuvery C, Bugg H, Bishop R, Davidson B and Vesikari T. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 1995; 13(2):168

 

1994

Simasathien S, Migasena S, Samakoses R, Pitisuttithum P, Sangaroon P, Aree C, Bishop R, Bugg H, Davidson B and Vesikari T. Vaccination of Thai infants with rhesus-human reassortant tetravalent (PRV-TV) rotavirus vaccine Pediatr. Infect Dis J 1994;13(7):590

Simasathien S, Migasena S, Beuvery C, Steenis G, Samakoses R, Pitisuttithum P and Vesikari T.Comparison of enhanced potency inactiated poliovirus vaccine (eIPV) versus standard oral poliovirus vaccine (OPV) in Thai infants. Scan J Infect Dis1994; 26:731-8

 

1993

Pitisuttithum P, Migasena S, Prayurahong B, Supanaranond W, Suntharasamai P, Supeeranan L, Chantra A and Naksrisook S. Pasteur oral cholera vaccine studies of reactogenicity, clinical acceptability and immunogenicity in human volunteers. Southeast Asian J Trop Med Pub Hlth 1993; 24(1):126

 

1992

Su-arehawaratana P, Singharaj P, Taylor D N, Hoge C, Trofa A, Kuvanont K, Migasena S, Pitisuttithum P, Lim Y L, Losonsky G, Kaper JB, Wesserman SS, Cryz S, Echeverria P. and Levine MM. Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand. J Infect Dis 1992;165(6):1042

Suntharasamai P, Migasena S, Vongsthongsri U, Supanaranond W, Pitisuttithum P, Supeeranan L, Chantra A and Naksrisook S. Clinical and bacteriological studies of El Tor cholera after ingestion of known inocula in Thai volunteers. Vaccine 1992; 10(8):502

1991

Migasena S, Pitisuttithum P and Desakorn V.Gnathostoma larva migrans among guests of a New Year party. Southeast Asian J Trop Med Public Health. 1991 Dec;22 suppl:225-7

 

1990

PitisuttithumP, MigasenaS, Suntharasamai P, Supanaranond W, Desakorn V and Prayurahong B. Immune responses following killed whole vibrio-B subunit oral cholera vaccine in human volunteers. Southeast Asian J Trop Med Pub Hlth 1990; 20:201-5

Migasena S, Pitisuttithum P, Prayurahong B, Supanaranond W, Desakorn V, Suntharasamai P, Vongthongsri U and Levine MM. Clinical acceptability immunogenicity colonizing potential and transmissibility of0 attenuated (A-B+) Vibrio cholerae classical Inaba live oral vaccine strain CVD 103-HgR in healthy young Thai adults. Infect Immun 1989; 57:3261

Pitisuttithum P, Prayurahong B, Migasena S and Sunthrasamai P.Relationship of vibiocidal antibodies to history of cholera vaccination in Thai adult volunteers. Southeast Asian J Trop Med Pub Hlth 1990; 21:219-24

Pitisuttithum P, Migasena S, Juntra A, Supeeranun L and Naksrisuk S. Socioeconomic status and prevalence of interstial parasitic infection in Thai adults resideing in and around Bangkok metropolis. J Med Assoc Thai 1990; 73:522-3

Supanaranond W, Migasena S, Pitisuttithum P and Suntharasamai P. Health status of Thai volunteer in a cholera vaccine trial. J Med Assoc Thai 1990; 73(10): 548-51

 

1989

Migasena S, Pitisuttithum P,Supanaranond W, Desakorn V, Prayurahong B and Suntharasamai P. Reactogenicity and immunogenicity of oral cholera vaccine in Thai volunteers. Southeast Asian J Trop Med Pub Hlth 1989; 19:423-8

Migasena S, Supanaranond W, Pitisuttithum P, Suntharasamai P and Supeeranun L. Dose finding studies of Procholeragenoid in Thai volunteers. Southeast Asian J Trop Med Pub Hlth 1989; 20:27-30

Migasena S, Pitisuttithum P, Suntharasamai P, Prayurahong B, Supanaranond W, Desakorn V and Black RE. Comparison of the reactivities and of immunogenicities of Procholeragenoid and the B-subunit of cholera toxin in Thai Volunteers. Infect Immun 1989; 57:1942-5

Migasena S, Pitisuttithum P, Prayurahong B, Suntharasamai P, Supanaranond W, Desakorn V, Vongthongsri U, Tall B, Ketley J, Losonsky G, et al. Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults. Infect Immun 1989 ;57(11);3261-4

Migasena S, Desakorn V, Suntharasamai P, Pitisuttithum P, Prayurahong B, Supanaranond W and Black RE. Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin. Infect Immun 1989; 57(1): 117-20

Pitisuttithum P, Migasena S, Suntharasamai P, Supanaranond W, Desakorn V and Prayurahong B. Immune responses following killed whole vibrio-B subunit oral cholera vaccine in human volunteers. Southeast Asian J Trop Med Public Health 1989; 20(2):201-5

 

1988

Pitisuttithum P, Migagena S, Suntharasama P and Supanaranond W. Factors influenzing the intestinal intubation in Thai adult volunteers. J Med Assoc Thai 1988; 71:351-4

Migasena S, Desakorn V, Suntharasamai P, Pitisuttithum P, Prayurahong B and Suntharasamai P. Reactogenicity and immunogenicity of oral cholera vaccine in Thai Volunteers. Southeast Asian J Trop Med Pub Hlth 1988; 19:423-8

 

 

 
Untitled Document